ANXA5 and neurodegenerative disease: Our preliminary data suggest that plasma annexin A5 levels of the six patients with depression was comparable with controls (data not shown), which might implicate annexin A5 as a biomarker for discriminating between neurodegenerative and non-neurodegenerative diseases.